Updated Jul 16, 2026
Burke Steven Keith is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $94K.
Burke Steven Keith is associated with Akebia Therapeutics, Inc., as indicated by recent SEC filings. Specific details about his role and contributions to the company are not widely documented in publicly available sources.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-04 | AKBA | Akebia Therapeutics, Inc. | S — Open-market sale [10b5-1] | 20.7K | $1.39 | $29K |
| 2026-02-04 | AKBA | Akebia Therapeutics, Inc. | S — Open-market sale [10b5-1] | 25.4K | $1.39 | $35K |
| 2026-02-04 | AKBA | Akebia Therapeutics, Inc. | S — Open-market sale [10b5-1] | 21.6K | $1.39 | $30K |
| 2026-02-03 | AKBA | Akebia Therapeutics, Inc. | A — Grant or award | 204.0K | $0.00 |
Burke Steven Keith is associated with Akebia Therapeutics, Inc., as indicated by recent SEC filings. Specific details about his role and contributions to the company are not widely documented in publicly available sources.…
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($94K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Burke Steven Keith profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.